INFANT'S ACETAMINOPHEN SUSPENSION DROPS 80 MG
ACETAMINOPHEN : 80 MG · DIN 02239625 · TANTA PHARMACEUTICALS INC
Health Canada status: APPROVED
What is INFANT'S ACETAMINOPHEN SUSPENSION DROPS?
INFANT'S ACETAMINOPHEN SUSPENSION DROPS 80 MG contains ACETAMINOPHEN : 80 MG. It is listed in the Health Canada Drug Product Database under DIN 02239625, held by TANTA PHARMACEUTICALS INC, supplied as SUSPENSION for ORAL administration. Health Canada currently lists it as approved, status dated 01-Feb-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is INFANT'S ACETAMINOPHEN SUSPENSION DROPS called?
The same molecule, ACETAMINOPHEN (PARACETAMOL), is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| PANDA | Latin | Bahrain |
| PANDA SIX PLUS | Latin | Bahrain |
| PANDA STRONG | Latin | Bahrain |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02239625 |
|---|---|
| Brand name | INFANT'S ACETAMINOPHEN SUSPENSION DROPS |
| Generic / active ingredient | ACETAMINOPHEN : 80 MG |
| Manufacturer | TANTA PHARMACEUTICALS INC |
| Strength | 80 MG |
| Dosage form | SUSPENSION |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | N02BE01 ACETAMINOPHEN (PARACETAMOL) |
| AHFS class | 28:08.92 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 01-Feb-1999 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02239625 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2239625 |
| Brand name | INFANT'S ACETAMINOPHEN SUSPENSION DROPS |
| Active ingredient / INN | ACETAMINOPHEN : 80 MG |
| ATC code | N02BE01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02 |
| AHFS class | 28:08.92 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | TANTA PHARMACEUTICALS INC |
Which pack is which?
| Strength on the label | 80 MG |
|---|---|
| Dosage form | SUSPENSION |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is ACETAMINOPHEN (PARACETAMOL) in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by APOTEX INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for INFANT'S ACETAMINOPHEN SUSPENSION DROPS
What can be used instead?
Other Canadian products sharing ATC code N02BE01 ACETAMINOPHEN (PARACETAMOL). 75 of 409 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACET 120 | 120 MG | SUPPOSITORY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02230434 |
| ACET 160 | 160 MG | SUPPOSITORY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02230435 |
| ACET 325 | 325 MG | SUPPOSITORY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02230436 |
| ACET 650 | 650 MG | SUPPOSITORY | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02230437 |
| ACETAMINOPHEN 160 MG CHEWABLE TABLETS | 160 MG | TABLET (CHEWABLE) | LABORATOIRES TRIANON INC. | MARKETED | DIN 02237562 |
| ACETAMINOPHEN 325MG TABLETS REGULAR STRENGTH | 325 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | MARKETED | DIN 02252805 |
| ACETAMINOPHEN 500 MG TABLETS EXTRA STRENGTH EASY TO SWALLOW | 500 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | MARKETED | DIN 02255251 |
| ACETAMINOPHEN 500MG TABLETS EXTRA STRENGTH | 500 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | MARKETED | DIN 02252813 |
| ACETAMINOPHEN ARTHRITIS PAIN | 650 MG | TABLET (EXTENDED-RELEASE) | PERRIGO INTERNATIONAL | MARKETED | DIN 02272482 |
| ACETAMINOPHEN CAPLETS 325 MG | 325 MG | TABLET | LABORATOIRES TRIANON INC. | MARKETED | DIN 01977415 |
How much does ACETAMINOPHEN (PARACETAMOL) cost around the world?
ACETAMINOPHEN (PARACETAMOL) is listed on 2 national price registers Nexara tracks, across 64 pack listings published on 2 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 11 | 60 | 03 Sep 2026 |
| Bahrain | retail (max) | 3 | 4 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ask about availability of INFANT'S ACETAMINOPHEN SUSPENSION DROPS
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.